Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is […]
List of articles in "Drug" category - Page 372
Maslimomab
Maslimomab is a mouse monoclonal antibody and an immunosuppressive drug.[citation needed]
Golimumab
Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha) a […]
Gomiliximab
Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23). The drug is a […]
Galiximab
Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009 it is undergoing Phase III clinical trials. The drug is a chimeric antibody from […]
Vepalimomab
Vepalimomab is a mouse monoclonal antibody developed for the treatment of inflammations. It blocks the vascular adhesion protein 1.
Odulimomab
Odulimomab is an investigational drug for the prevention of transplant rejection and for the treatment of various immunological diseases.It is a mouse monoclonal antibody directed against the alpha chain of […]
Inolimomab
Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor.
Elsilimomab
Elsilimomab (also known as B-E8) is a mouse monoclonal antibody and an immunosuppressive drug.[citation needed]It (OPR-003) targets (and blocks) Interleukin-6.It has undergone a number of early stage clinical trails e.g. […]
Zolimomab aritox
Zolimomab aritox is a mouse monoclonal antibody which has been investigated for the treatment of systemic lupus erythematosus and graft-versus-host disease but the studies failed to show positive effects of […]